Pharmacogenomics Testing - MEDICAID - SOUTH CAROLINA

Pharmacogenomics testing (DNA- and RNA-based panels and single-gene assays such as CYP2D6, TPMT, NUDT15, DPYD/IFNL3, CEP72 and multi-gene panels) to guide drug metabolism and selection for psychiatry (depression, anxiety, ADHD), oncology (including predicted response to immune checkpoint inhibitors), autoimmune disease (psoriasis biologic response), ophthalmology (AMD risk related to supplements), and other drug-response indications. Coverage is governed by the member’s plan and cited clinical guidelines (CPIC, AMP, etc.); the excerpt lists no explicit frequency/age/prior‑authorization rules, and notes some assays are considered investigational or may be excluded for certain members (e.g., specific tests not covered for Humana members).

"Mind."

Sign up to see full coverage criteria, indications, and limitations.